Qualifying for a clinical trial for lung cancer is not an easy decision to make. It requires a lot from the person who plans on undergoing the trial because of the risks which is incorporated with the different trials made.
A participant who is to undergo such a procedure is required to be firm with the decision and should understand the different benefits and risks which will be thoroughly discussed by your doctor. When you have convinced yourself that you are ready for the consequences, then you can qualify for the test.
A clinical trial is a study designed to evaluate a newer treatment for a certain disease. In order to make up a decision, you must first know how the procedure is being administered. However, it is also vital to remember that majority of cases being treated with the new regimen has shown promising effects than that of the usual modalities and current therapies.
People who are into clinical trials are taken care of by experts who closely monitor their patient’s development and personal well-being. On the other hand, people who undergoes this procedure are the ones who will first receive the newest treatments provided that their health and any kind of progress or side effect is thoroughly monitored by the researchers and doctors involved.
Usually, clinical trials are set up in a way that the patients are assigned in a random manner to a particular group that is bound to receive the accepted standard of treatment or any kind of experimental intervention. Initially, the first patients will receive the current therapy there is. While the next set of patients belonging to the experimental group will receive the newest found treatment. For the people who are receiving a newer version of the treatment can mean several things which will depend on the trial that was designated. It’s either a new combination of medications and procedures, new drugs, new way of administering the drug and new dosages. Clinical trials are usually made up of four different phases wherein a number of people are asked to participate.
A clinical trial tends to end when there is already enough satisfying information gathered in order to answer whether the new discovery was successful in the fight against lung cancer. Some of the reasons would be:
1. The drug is a definite cure or can allow a person affected with the disease to live longer compared to the current therapies.
2. Positive effects are evident in providing a better quality of life for a cancer patient such as experiencing fewer drug side effects, normal body weigh maintenance, and having a more effective coping mechanism.
3. Amount of remission time of a cancer patient.
In order to know if you are ready to receive clinical trial you must first evaluate the basic advantages and disadvantages it may contribute to your condition. You should understand the different treatments that is offered by the researchers. When the options are laid down, you must be able to understand the different procedures that will be done apart from the standardized treatment of your lung cancer. By then you will be able to decide and eventually qualify for a clinical trial for lung cancer.
By Charlene J. Nuble